Zavorno in nadomestno zdravljenje s ščitničnimi hormoni

Show document
A+ | A- | | SLO | ENG

Title:	Zavorno in nadomestno zdravljenje s ščitničnimi hormoni
Authors:	ID Bešić, Nikola (Author)
Files:	PDF - Presentation file, download (190,66 KB) MD5: AF30B70E76FDDD45C5DBA0170AAC0703 PID: 20.500.12556/dirros/5d124fdf-7174-425d-a132-4371e93f53a7
Language:	Slovenian
Typology:	1.04 - Professional Article
Organization:	OI - Institute of Oncology
Publication status:	Published
Publication version:	Version of Record
Year of publishing:	2008
Number of pages:	str. 33-34
Numbering:	Letn. 12, št. 1
PID:	20.500.12556/DiRROS-8666
UDC:	616-006
ISSN on article:	1408-1741
URN:	URN:NBN:SI:doc-88Y0MQWP
COBISS.SI-ID:	619131
Copyright:	by Authors
Publication date in DiRROS:	31.08.2018
Views:	3045
Downloads:	873
Metadata:
:	Copy citation

Share:

Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

License:	CC BY 4.0, Creative Commons Attribution 4.0 International

Link:	http://creativecommons.org/licenses/by/4.0/
Description:	This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:	31.08.2018

Language:	English
Title:	Suppressive and Substitution Therapy with Thyroid Hormones
Abstract:	A patient with papillary or follicular thyroid carcinoma and unfavorable prognostic factors should have low serum TSH level in order to diminish the risk of recurrence. However, in order to prevent side effects on target organs (heart, bones), the levels of thyroid hormones should be inside the normal reference range. Whenever the thyroid doesn't produce enough hormones in a patient with a benign thyroid disease, the patient should be treated with a hormone replacement therapy. The aim of the substitution therapy is that TSH, free T4 and free T3 are inside the normal reference ranges. Bioequivalence of different generic drugs with thyroxin may differ from 12.5 to 25%. Therefore, if one thyroxine drug is changed with another one, a laboratory test of TSH level has to be performed after six weeks.